Related Experiment Video
Updated: Aug 9, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Eric F Morand1, Michelle Leech, Jürgen Bernhagen
1Centre for Inflammatory Diseases, Monash Institute for Medical Research, 246 Clayton Road, Clayton, Victoria 3168, Australia. eric.morand@med.monash.edu.au
Abstract:
Macrophage migration inhibitory factor (MIF) is well established as a key cytokine in immuno-inflammatory diseases such as rheumatoid arthritis. Inflammation is now also recognized as having a crucial role in atherosclerosis, and recent evidence indicates that MIF could also be important in this disease. Here, we review the role of MIF in rheumatoid arthritis and atherosclerosis, discuss the ways in which MIF and its relationship with glucocorticoids could link these diseases, and consider the potential of MIF as a new therapeutic target for small-molecule and antibody-based anti-cytokine drugs.
Related Concept Videos
The JAK-STAT Signaling Pathway
Rheumatic Heart Disease I: Introduction
Atherosclerosis I: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Inflammation